Current Atherosclerosis Reports

Papers
(The TQCC of Current Atherosclerosis Reports is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Revascularization Options for Left Main Disease: What Clinicians Need to Know103
The Expanding Scope of GLP-1 Receptor Agonists: Six Uses Beyond Diabetes100
Are Clinicians Aggressive Enough in Treating Diabetes-Related Hyperlipidemia in Youth?98
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?81
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American Heart Association Scientific Sessions79
The Greatly Under-Represented Role of Smooth Muscle Cells in Atherosclerosis63
A Narrative Review of the Association Between Depression and Heart Disease Among Women: Prevalence, Mechanisms of Action, and Treatment62
Polysocial Risk Scores: Implications for Cardiovascular Disease Risk Assessment and Management62
Heart Transplant, Kawasaki Disease, and Bone Marrow Transplant: Are There Consequences?62
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?60
Anti-apoC-III Therapies and Implications for Treatment of Pancreatitis and Cardiovascular Disease58
Watermelon and l-Citrulline in Cardio-Metabolic Health: Review of the Evidence 2000–202058
The Effects of FABP4 on Cardiovascular Disease in the Aging Population53
Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management53
Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women52
Salutary Effects of Nutritional Ketosis for the Diseased Human Heart46
Effects of Pioglitazone On Lipoprotein(a): A Meta-analysis45
DOACs and Atherosclerotic Cardiovascular Disease Management: Can We Find the Right Balance Between Efficacy and Harm44
Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond44
Spontaneous Coronary Artery Dissection (SCAD): Unveiling the Enigma of the Unexpected Coronary Event42
Genetic Testing for Familial Hypercholesterolemia in Clinical Practice41
From ‘Omics to Multi-omics Technologies: the Discovery of Novel Causal Mediators39
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?38
The Emerging Specialty of Cardio-Rheumatology36
Recent Advances and Perspectives of Metabolomics-Based Investigations in Coronary Heart Disease36
Correction to: Beta‑blockers for Atherosclerosis Prevention: a Missed Opportunity?34
Programmable Genome-Editing Technologies as Single-Course Therapeutics for Atherosclerotic Cardiovascular Disease34
Nutrition Interventions for Youth with Dyslipidemia: Who, What, When, and Where?33
The Role of Non-Statin Lipid Lowering Therapies to Reduce ASCVD Events in Primary Prevention33
GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?32
Percutaneous Coronary Interventions in Women32
Inflammation in the Peri-ACS Period: Ready for Prime Time?31
Lipoprotein(a): from Causality to Treatment30
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women30
The Intersection Between COVID-19, Cardiovascular Disease, and Diet: a Review29
Myeloid Cells in Abdominal Aortic Aneurysm29
The Role of Sleep in Cardiovascular Disease28
The Role of Bacterial Extracellular Membrane Nanovesicles in Atherosclerosis: Unraveling a Potential Trigger28
Low LDL-C: Is It all Good News?27
Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease26
Role of RNA-binding Proteins in Regulating Cell Adhesion and Progression of the Atherosclerotic Plaque and Plaque Erosion24
Importance of Nutrition Security to CVD Prevention Efforts in the USA24
In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?24
Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know?24
Childhood Hypertriglyceridemia: Is It Time for a New Approach?23
Stress, Vascular Smooth Muscle Cell Phenotype and Atherosclerosis: Novel Insight into Smooth Muscle Cell Phenotypic Transition in Atherosclerosis23
Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know22
Transgender Cardiovascular Health: Practical Management for the Clinician22
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment22
Effects of Omega-3 Fatty Acids on Flow-mediated Dilatation and Carotid Intima Media Thickness: A Meta-analysis22
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity20
Update on Plant-Based Diets and Cardiometabolic Risk20
Transforming Population Health Screening for Atherosclerotic Cardiovascular Disease with AI-Enhanced ECG Analytics: Opportunities and Challenges20
Is Family History for the Management of Cardiovascular Health in Youth Still Relevant in Clinical Practice?20
Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?20
Correction to: High-Density Lipoproteins and Serum Amyloid A (SAA)20
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 European Society of Cardiology Conference19
Noninvasive Atherosclerotic Phenotyping: The Next Frontier into Understanding the Pathobiology of Coronary Artery Disease18
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference18
Membrane Cholesterol Interactions with Proteins in Hypercholesterolemia-Induced Endothelial Dysfunction18
Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know17
Gene Regulatory Networks in Coronary Artery Disease17
Factors Affecting Circulating Phytosterol Levels: Toward an Integrated Understanding of Atherogenicity and Atheroprotection by Dietary and Circulating Phytosterols17
Clinical Management of Dyslipidemia in Infants and Toddlers17
SR-B1’s Next Top Model: Structural Perspectives on the Functions of the HDL Receptor17
Evidence Gaps in Assessments of the Healthiness of Online Supermarkets Highlight the Need for New Monitoring Tools: a Systematic Review17
Is There a Role for Imaging Youth at Risk of Atherosclerosis?17
Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?17
Dairy Foods: Is Its Cardiovascular Risk Profile Changing?17
Brief Review: Racial and Ethnic Disparities in Cardiovascular Care with a Focus on Congenital Heart Disease and Precision Medicine16
Cardiovascular Disease in the Middle East and North Africa, 1990–2021: Burden, Trends, and Risk Factors16
HIV and Cardiovascular Disease Burden in Young Adults (18–25 years): A Review of Current Evidence16
High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review15
Expanding Clinical Indications for Cardiac CT: A Review of Its Current Utility in American and European Guidelines15
What Causes Premature Coronary Artery Disease?15
Cardiovascular Health and Disease in the Pakistani American Population15
Wall Shear Stress Alteration: a Local Risk Factor of Atherosclerosis15
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American College of Cardiology Conference15
Pharmacotherapy for Coronary Artery Disease and Acute Coronary Syndrome in the Aging Population15
Combined Dyslipidemia in Children and Adolescents: a Proposed New Management Approach14
Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician14
Utility of FFRCT in Patients with Chest Pain14
Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field14
Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults14
Targeting the Gut Microbiome to Treat Cardiometabolic Disease14
Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins14
Biology, Bias, or Both? The Contribution of Sex and Gender to the Disparity in Cardiovascular Outcomes Between Women and Men14
Bempedoic Acid: for Whom and When14
Natural Sirtuin1 Activators and Atherosclerosis: an Overview14
Fixed Combination for the Treatment of Dyslipidaemia13
The Role of Lysyl Oxidase in the Pathological Stage of Atherosclerosis: Structural Stabilizer or Disease Driver?13
Serial Coronary CTA for Monitoring Response to Lipid-Lowering Therapy: A Narrative Review13
Anti-Inflammatory Lipid Mediators from Polyunsaturated Fatty Acids: Insights into their Role in Atherosclerosis Microenvironments13
A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms13
Extra-coronary Calcification and Cardiovascular Events: What Do We Know and Where Are We Heading?13
Dietary Management of Atherogenic Dyslipidemia13
0.17324900627136